Purpose: Pulmonary Kv channels are thought to play a crucial role in the regulation of cell proliferation and apoptosis. Previous studies have shown that fluoxetine upregulated the expression of Kv1.5 and prevented pulmonary arterial hypertension in monocrotaline-induced or hypoxia-induced rats and mice. The current study was designed to test how fluoxetine regulates Kv1.5 channels, subsequently promoting apoptosis in human PASMCs cultured in vitro.
Materials And Methods: Human PASMCs were incubated with low-serum DMEM, ET-1, and fluoxetine with and without ET-1 separately for 72 h. Then the proliferation, apoptosis, and expression of TRPC1 and Kv1.5 were detected.
Results: In the ET-1 induced group, the upregulation of TRPC1 and down regulation of Kv1.5 enhanced proliferation and anti-apoptosis, which was reversed when treated with fluoxetine. The decreased expression of TRPC1 increased the expression of Kv1.5, subsequently inhibiting proliferation while promoting apoptosis.
Conclusion: The results from the present study suggested that fluoxetine protects against big endothelin-1 induced anti-apoptosis and rescues Kv1.5 channels in human pulmonary arterial smooth muscle cells, potentially by decreasing intracellular concentrations of Ca²⁺.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381489 | PMC |
| http://dx.doi.org/10.3349/ymj.2012.53.4.842 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of K1.3 and K1.5 channels.
Biomed Pharmacother
May 2023
Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), 28029 Madrid, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain. Electronic address:
Immune cells have an important role in the tumor-microenvironment. Macrophages may tune the immune response toward inflammatory or tolerance pathways. Tumor-associated macrophages (TAM) have a string of immunosuppressive functions and they are considered a therapeutic target in cancer.
View Article and Find Full Text PDFSigma-1 receptor modulation fine-tunes K1.5 channels and impacts pulmonary vascular function.
Pharmacol Res
March 2023
Department of Pharmacology and Toxicology, School of Medicine, University Complutense of Madrid, Madrid, Spain; Ciber Enfermedades Respiratorias (CIBERES), Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. Electronic address:
K1.5 channels are key players in the regulation of vascular tone and atrial excitability and their impairment is associated with cardiovascular diseases including pulmonary arterial hypertension (PAH) and atrial fibrillation (AF). Unfortunately, pharmacological strategies to improve K1.
View Article and Find Full Text PDFPseudosaccharin amines as potent and selective KV1.5 blockers.
Bioorg Med Chem Lett
November 2015
Bristol-Myers Squibb Research and Development, PO Box 5400, Princeton, NJ 08534-5400, USA.
Phenethyl aminoheterocycles like compound 1 were known to be potent I(Kur) blockers although they lacked potency in vivo. Modification of the heterocycle led to the design and synthesis of pseudosaccharin amines. Compounds such as 14, 17d and 21c were found to be potent K(V)1.
View Article and Find Full Text PDFDesign, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitors.
Bioorg Med Chem Lett
July 2014
Department of Discovery Chemistry, Bristol-Myers Squibb Research and Development, PO Box 5400, Princeton, NJ 08534-5400, USA.
Phenethylaminoheterocycles have been prepared and assayed for inhibition of the Kv1.5 potassium ion channel as a potential approach to the treatment of atrial fibrillation. A diverse set of heterocycles were identified as potent Kv1.
View Article and Find Full Text PDFMultiple mRNA isoforms encoding the mouse cardiac Kv1-5 delayed rectifier K+ channel.
J Biol Chem
November 1993
Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.
Article Synopsis
- Researchers cloned the mouse Kv1-5 K+ channel cDNA from heart tissue, finding high expression in the heart and lower levels in the brain and thymus.
- Two isoforms were identified: a longer one with 602 amino acids and a shorter variant (Kv1-5 delta 5') missing the first 200 amino acids due to splicing.
- Both isoforms were present in various mouse tissues, with the longer form being more common; the carboxyl-terminal truncated form (Kv1-5 delta 3') was found to be nonfunctional but inhibited the longer isoform's expression.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!